Edward Abraham
Impact in
-
- Intensive Care Unit Cognitive Disorders
- Clinical Biochemistry top 0.01%
- Advanced Glycation End Products research
Papers in
- Immunology 141
- Immune Response and Inflammation 110
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 37
- Immune cells in cancer 18
-
- Respiratory Support and Mechanisms 56
- Neonatal Respiratory Health Research 24
- Co-authors
- Steven M. Opal (9 shared papers)Jean‐Louis Vincent (9 shared papers)Gang Liu (38 shared papers)Jonathan Cohen (5 shared papers)John C. Marshall (4 shared papers)Mitchell M. Levy (5 shared papers)Derek C. Angus (5 shared papers)Mitchell P. Fink (3 shared papers)
- Journals
- Critical Care Medicine (56 papers)The Journal of Immunology (30 papers)American Journal of Respiratory and Critical Care Medicine (21 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (18 papers)Intensive Care Medicine (10 papers)
- Partner nations
- United StatesFranceSouth Korea
In The Last Decade
Edward Abraham
335 papers receiving 37.2k citations
Edward Abraham's Hit Papers
Peers
Comparison fields: 5 of 183
- Critical Care and Intensive Care Medicine 4.7k
- Clinical Biochemistry 5.3k
- Immunology 12.5k
- Epidemiology 12.4k
- Nephrology 2.1k
Countries citing papers authored by Edward Abraham
This map shows the geographic impact of Edward Abraham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward Abraham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward Abraham more than expected).
Fields of papers citing papers by Edward Abraham
This network shows the impact of papers produced by Edward Abraham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward Abraham. The network helps show where Edward Abraham may publish in the future.
Co-authors
The 25 scholars most cited alongside Edward Abraham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 337 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Hit paper breakdown → | 2003 | 4516 |
| 2 | HMG-1 as a Late Mediator of Endotoxin Lethality in Mice Hit paper breakdown → | 1999 | 2808 |
| 3 | 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Hit paper breakdown → | 2003 | 2077 |
| 4 | Involvement of Toll-like Receptors 2 and 4 in Cellular Activation by High Mobility Group Box 1 Protein Hit paper breakdown → | 2004 | 1309 |
| 5 | Treatment of Septic Shock with the Tumor Necrosis Factor Receptor:Fc Fusion Protein Hit paper breakdown → | 1996 | 930 |
| 6 | miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis Hit paper breakdown → | 2010 | 783 |
| 7 | High mobility group box 1 protein interacts with multiple Toll-like receptors Hit paper breakdown → | 2005 | 779 |
| 8 | Neutrophils and acute lung injury Hit paper breakdown → | 2003 | 720 |
| 9 | Efficacy and Safety of Monoclonal Antibody to Human Tumor Necrosis Factor α in Patients With Sepsis Syndrome Hit paper breakdown → | 1995 | 621 |
| 10 | Cutting Edge: HMG-1 as a Mediator of Acute Lung Inflammation Hit paper breakdown → | 2000 | 610 |
| 11 | Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of Death Hit paper breakdown → | 2005 | 567 |
| 12 | Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group. | 1998 | 490 |
| 13 | 2004 | 486 | |
| 14 | 2005 | 467 | |
| 15 | 2005 | 409 | |
| 16 | Metformin reverses established lung fibrosis in a bleomycin model Hit paper breakdown → | 2018 | 407 |
| 17 | 2003 | 378 | |
| 18 | 2009 | 373 | |
| 19 | 1998 | 369 | |
| 20 | 2010 | 350 |
About Edward Abraham
Edward Abraham is a scholar working on Immunology, Pulmonary and Respiratory Medicine, Epidemiology, Molecular Biology and Cancer Research, having authored 337 papers that have together received 38.0k indexed citations. Recurring topics across this work include Immune Response and Inflammation (110 papers), Sepsis Diagnosis and Treatment (84 papers), Respiratory Support and Mechanisms (56 papers), NF-κB Signaling Pathways (37 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (37 papers), Advanced Glycation End Products research (24 papers), Neonatal Respiratory Health Research (24 papers) and Immune cells in cancer (18 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (4.7k citations), Clinical Biochemistry (5.3k citations), Immunology (12.5k citations), Epidemiology (12.4k citations) and Nephrology (2.1k citations). Edward Abraham has collaborated with scholars based in United States, France and South Korea. Frequent co-authors include Steven M. Opal, Jean‐Louis Vincent, Gang Liu, Jonathan Cohen, John C. Marshall, Mitchell M. Levy, Derek C. Angus, Mitchell P. Fink, Graham Ramsay and Robert Shenkar. Their work appears in journals such as Critical Care Medicine, The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine, American Journal of Physiology-Lung Cellular and Molecular Physiology and Intensive Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.